Using Smart-seq2, investigators further identified ESRP1/2 as critical regulators of FGFR2 splicing during EMT, thereby providing mechanistic insight into how splicing contributes to tumor plasticity.263. This evidence concerns the gene ESRP1 and neoplasm.